Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Lu-Yao, P. Albertsen, D. Moore, W. Shih, Yong Lin, R. DiPaola, M. Barry, A. Zietman, M. O’Leary, E. Walker-Corkery, S. Yao (2009)
Outcomes of localized prostate cancer following conservative management.JAMA, 302 11
J. Hugosson, S. Carlsson, G. Aus, S. Bergdahl, A. Khatami, P. Lodding, C. Pihl, J. Stranne, E. Holmberg, H. Lilja (2010)
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.The Lancet. Oncology, 11 8
S. Loeb, Y. Folkvaljon, C. Curnyn, D. Robinson, O. Bratt, P. Stattin (2017)
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in SwedenJAMA Oncology, 3
J. Tosoian, M. Mamawala, J. Epstein, P. Landis, S. Wolf, B. Trock, H. Carter (2015)
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 30
Paul Womble, J. Montie, Zaojun Ye, S. Linsell, B. Lane, David Miller (2015)
Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.European urology, 67 1
Ronald Chen, R. Rumble, D. Loblaw, A. Finelli, B. Ehdaie, M. Cooperberg, S. Morgan, S. Tyldesley, J. Haluschak, W. Tan, S. Justman, S. Jain (2016)
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 18
M. Cooperberg, J. Cowan, J. Hilton, A. Reese, H. Zaid, S. Porten, K. Shinohara, M. Meng, Kirsten Greene, P. Carroll (2011)
Outcomes of active surveillance for men with intermediate-risk prostate cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 2
M. Cooperberg, P. Carroll (2015)
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.JAMA, 314 1
Research Brief Report Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden ARTICLE INFORMATION Disclaimer: The content is solely the responsibility 5. Loeb S, Berglund A, Stattin P. Population based of the authors and does not represent the official study of use and determinants of active surveillance Accepted for Publication: June 23, 2016. views of the NIH. and watchful waiting for low and intermediate risk Published Online: October 20, 2016. prostate cancer. J Urol. 2013;190(5):1742-1749. Previous Presentation: An abstract based on these doi:10.1001/jamaoncol.2016.3600 data were presented at the American Urological 6. Tomic K, Berglund A, Robinson D, et al. Capture Author Contributions: Mr Folkvaljon had full Association meeting; May 6, 2016; San Diego, CA. rate and representativity of The National Prostate access to all the data in the study and takes Cancer Register of Sweden. Acta Oncol. 2015;54(2): Additional Contributions: This project was made responsibility for the integrity of the data and the 158-163. possible by the continuous work of the National accuracy of the data analysis. Prostate Cancer Register of Sweden (NPCR) steering 7. Van Hemelrijck M, Wigertz A, Sandin F, et al; Study concept and design: Loeb, Folkvaljon, Bratt, committee: Pär Stattin, MD, PhD, chairman; Anders NPCR and
JAMA Oncology – American Medical Association
Published: Oct 20, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.